慢性缺血性中风患者的人类神经干细胞 (PISCES):第一阶段,首次对人进行研究
Dheeraj Kalladka1, John Sinden2, Kenneth Pollock2
1Institute of Neuroscience and Psychology, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.
Lancet (London, England)
|August 8, 2016
概括
一种干细胞疗法CTX-DP在多达2000万细胞的中风患者中没有出现不良反应. 这种试验性治疗证明了神经功能的改善,支持进一步的中风恢复临床试验.
科学领域:
- 神经科学
- 复原医学
- 临床神经学
背景情况:
- CTX0E03是一种用于开发CTX-DP的神经干细胞系.
- 在CTX-DP治疗中风后,在小鼠中进行的临床前研究显示,有剂量依赖的感觉运动功能的改善.
- 这些发现促使研究CTX-DP在人类中风患者的安全性和耐受性.
研究的目的:
- 在经历过缺血性中风的患者中评估CTX- DP的安全性和耐受性.
- 评估CTX-DP脑内注射后的神经变化和不良事件.
主要方法:
- 进行了一项开放式,单位,剂量升级的研究.
- 11名60岁以上的男性患者经过缺血性中风后获得单剂量CTX- DP (2 - 20百万细胞) 通过立体注射.
- 安全终点包括2年随访期间的不良事件和神经学评估.
主要成果:
- 在11名参与者中没有观察到免疫或细胞相关的不良事件.
- 发现了与手术相关的不良反应或伴随疾病的不良反应.
- 五名患者在注射通道周围显示T2加权的MRI超强度.
- 在2年后,NIHSS得分的中位数提高了2分.
结论:
- 在患有慢性缺血性中风的患者中,CTX-DP的单剂量高达2000万个细胞被发现是安全的,并且耐受良好.
- 观察到的神经改善表明CTX-DP对中风患者的治疗具有前景.
- 基于这些安全性和初步疗效发现,需要对CTX- DP进行进一步的临床研究.
相关概念视频
Stem Cell Culture
6.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.5K
iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Induced Pluripotent Stem Cells
28.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.4K


